Esperion Therapeutics Inc (ESPR)
2.00
-0.03
(-1.48%)
USD |
NASDAQ |
Nov 04, 16:00
2.01
+0.01
(+0.50%)
After-Hours: 20:00
Esperion Therapeutics Debt to Equity Ratio: -0.7625 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | -0.7625 |
| March 31, 2024 | -0.8904 |
| December 31, 2023 | -0.5749 |
| September 30, 2023 | -0.637 |
| June 30, 2023 | -0.701 |
| March 31, 2023 | -0.7896 |
| December 31, 2022 | -0.8027 |
| September 30, 2022 | -0.8823 |
| June 30, 2022 | -0.8882 |
| March 31, 2022 | -1.039 |
| December 31, 2021 | -1.311 |
| Date | Value |
|---|---|
| September 30, 2021 | -0.7513 |
| June 30, 2021 | -0.8941 |
| March 31, 2021 | -1.008 |
| December 31, 2020 | -1.866 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-1.866
Minimum
Dec 2020
--
Maximum
Dec 2019
-0.7262
Average
-0.7896
Median
Mar 2023
Debt to Equity Ratio Benchmarks
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 352.32M |
| Total Liabilities (Quarterly) | 696.54M |
| Shareholders Equity (Quarterly) | -344.22M |
| Current Ratio | 1.968 |
| Net Debt Paydown Yield | -0.10% |